All lobbying filings

Arentfox Schiff LLP

Arentfox Schiff LLP filed a Q4 report for Pharvaris, Inc. on January 20, 2026, reporting $30,000 in lobbying income.

Lobbying for Pharvaris, Inc. · Late-stage biopharmaceutical company

As filed: ARENTFOX SCHIFF LLP for PHARVARIS, INC.

All filings by Arentfox Schiff LLP · Everything Pharvaris, Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Lobbyists on this filing 1

KELSEY GRISWOLD-BERGER New on this filing

Previously held: Sr Policy Advisor, Sen McCormick (2025); LA, Sen Burr (2021-23); Leg Dir, Rep C Smith (2018-21); Leg Dir, Rep Pittenger (2018); Leg Dir, Rep Blum (2017-18); LA, Rep Perry (2015-17); LA (2014-15), LC/Press Asst (2011-14), SA (2011), Rep Reed

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Advocacy of policies, legislation and coverage of new pharmaceuticals in the orphan drug space.

Pharmacy

Advocacy of policies, legislation and regulation pertaining to pharmaceutical manufacturing, focusing on orphan drug production.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.